The Global Glaucoma Treatment Industry, currently valued at US$ 5.7 billion as of the end of 2022, is poised for substantial growth. Projections indicate a Compound Annual Growth Rate (CAGR) of 3.2% during the forecast period from 2023 to 2033. By the end of 2033, the market is expected to reach a value of approximately US$ 8.0 billion The prevalence of glaucoma among the elderly …